Search found 8 matches
- Sun Jan 10, 2016 7:59 am
- Forum: ImetelChat
- Topic: New patent
- Replies: 7
- Views: 4311
Re: New patent
In the US, doctors don't concern themselves with the cost of the treatment. They are afraid of being sued for multiple millions for malpractice for failing to prescribe the best available treatment for a patient. The insurance companies are concerned with the price but the limited number of patients...
- Sun Dec 20, 2015 7:53 pm
- Forum: ImetelChat
- Topic: Yesterday volume 15 mln, AH 5 mln: what happened?
- Replies: 3
- Views: 3183
Re: Yesterday volume 15 mln, AH 5 mln: what happened?
Part 2 - I hit submit without mentioning that there were over 5,500 $5 call options expiring on Friday (550,000 shares) that the holders would have been willing to sell had the share price approached within a few pennies that number, providing a buffer allowing the shorts to agree to a price near th...
- Sun Dec 20, 2015 7:42 pm
- Forum: ImetelChat
- Topic: Yesterday volume 15 mln, AH 5 mln: what happened?
- Replies: 3
- Views: 3183
Re: Yesterday volume 15 mln, AH 5 mln: what happened?
Institutional shorts can cover by negotiated agreement, which includes price and time of sale, with other institutions that own shares. The exchange requires those transactions to be reported through the exchange within a short time frame (like 30 seconds after completion). The transactions were des...
- Tue Dec 15, 2015 10:58 pm
- Forum: ImetelChat
- Topic: Geron: Calcualting the Potential Value Gap
- Replies: 3
- Views: 3176
Re: Geron: Calcualting the Potential Value Gap
Your points are well thought out. There is a constant clash between the cost of treatment and the entities that pay for the treatment (insurance companies, government, individuals) that comes into play whenever pricing is concerned. We have seen that once a medicine is approved, the price to the pat...
- Tue Dec 15, 2015 5:47 am
- Forum: ImetelChat
- Topic: My take on Geron's strategy in the JnJ partnership
- Replies: 1
- Views: 2750
Re: My take on Geron's strategy in the JnJ partnership
The partnership with Janssen is limited to Imetelstat only. It is very clear from the agreement that any use of Imetelstat would have to include Janssen. I would like to see activity partnering with other big pharma companies rather than limiting the business relationship to J&J only. The value of a...
- Mon Dec 14, 2015 11:02 pm
- Forum: ImetelChat
- Topic: Geron: Calcualting the Potential Value Gap
- Replies: 3
- Views: 3176
Re: Geron: Calcualting the Potential Value Gap
The value gap exists because there is currently no Geron product on the market (ignoring the relatively small license fees for diagnostic tests) and the stock is being actively manipulated by the people that are currently short 31 million shares. It is hard to place a firm number on the size of the ...
- Thu Dec 10, 2015 3:08 am
- Forum: ImetelChat
- Topic: Fisher, you did it!!
- Replies: 6
- Views: 5135
Re: Fisher, you did it!!
Thank you for setting up this board. I am willing to assist you in any way I can at your request.
What a pleasant visit I had on my first trip to your site.
What a pleasant visit I had on my first trip to your site.
- Thu Dec 10, 2015 2:58 am
- Forum: ImetelChat
- Topic: Take aways from Oppenheimer
- Replies: 6
- Views: 5352
Re: Take aways from Oppenheimer
Fishermangents, Excellent post and thank you for making this forum available. If there is anything I can do to assist you with administration, funding, or anything else related to this site, just post a message to me or email me at my registration email and I will get going on it. I think the move b...